Abstract CT119: Zilovertamab vedotin in pediatric and young adult hematologic malignancies or solid tumors: Phase 1/2 LIGHTBEAM-U01A study

Hyoung Jin Kang; Pablo Berlanga; Quentin Campbell-Hewson; Steven G. DuBois; Kyung-Nam Koh; Christine Mauz-Koerholz; Michael Sullivan; David Mangum; Rachael Windsor; David S. Dickens; Alexandre Duarte; Farzana Pashankar; Shifra Ash; Andrew Bellantoni; Scott J. Diede; Rohini Singh; Yulia Sidi; Michal Yalon

doi:10.1158/1538-7445.AM2025-CT119

Back

Abstract

Peer reviewed

Abstract CT119: Zilovertamab vedotin in pediatric and young adult hematologic malignancies or solid tumors: Phase 1/2 LIGHTBEAM-U01A study

Hyoung Jin Kang, Pablo Berlanga, Quentin Campbell-Hewson, Steven G. DuBois, Kyung-Nam Koh, Christine Mauz-Koerholz, Michael Sullivan, David Mangum, Rachael Windsor, David S. Dickens, …

Cancer research (Chicago, Ill.), Vol.85(8_Supplement_2), pp.CT119-CT119

04/25/2025

DOI: 10.1158/1538-7445.AM2025-CT119

View Online

Details

Title: Subtitle: Abstract CT119: Zilovertamab vedotin in pediatric and young adult hematologic malignancies or solid tumors: Phase 1/2 LIGHTBEAM-U01A study
Creators: Hyoung Jin Kang
Pablo Berlanga
Quentin Campbell-Hewson
Steven G. DuBois
Kyung-Nam Koh
Christine Mauz-Koerholz
Michael Sullivan
David Mangum
Rachael Windsor
David S. Dickens
Alexandre Duarte
Farzana Pashankar
Shifra Ash
Andrew Bellantoni
Scott J. Diede
Rohini Singh
Yulia Sidi
Michal Yalon
Resource Type: Abstract
Publication Details: Cancer research (Chicago, Ill.), Vol.85(8_Supplement_2), pp.CT119-CT119
Publisher: AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1538-7445.AM2025-CT119
ISSN: 0008-5472
eISSN: 1538-7445
Language: English
Date published: 04/25/2025
Academic Unit: Stead Family Department of Pediatrics; Hematology/Oncology
Record Identifier: 9984820571902771

Metrics

1 Record Views